A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT03586830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effects of JNJ-64565111 compared with placebo in severely obese Type 2 Diabetes Mellitus (T2DM) participants after 12 weeks of treatment on: the percentage change in body weight from baseline and safety and tolerability.
Study identification
- NCT ID
- NCT03586830
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Interventions
- JNJ-64565111 Dose Level 1 Drug
- JNJ-64565111 Dose Level 2 Drug
- JNJ-64565111 Dose Level 3 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2018 (Actual)
- Primary completion
- Apr 5, 2019 (Actual)
- Completion
- Apr 5, 2019 (Actual)
- Last update posted
- Jan 7, 2020
2018 – 2019
United States locations
- U.S. sites
- 27
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates, Inc. | Birmingham | Alabama | 35205 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Rancho Cucamonga Clinical Trials | Rancho Cucamonga | California | 91730 | — |
| Sierra Clinical Research | Roseville | California | 95661 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Premeir Clinical Research Institute | Miami | Florida | 33122 | — |
| International Research Associates, LLC | Miami | Florida | 33183 | — |
| CNS HealthCare | Orlando | Florida | 32801 | — |
| Translational Research Institute for Metabolism and Diabetes | Orlando | Florida | 32804 | — |
| Buynak Clinical Research | Valparaiso | Indiana | 46383 | — |
| Cotton-O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| M.D. Medical Research | Oxon Hill | Maryland | 20745 | — |
| AAMRC | Flint | Michigan | 48504 | — |
| Alas Science Clinical Research | Henderson | Nevada | 89014 | — |
| Prestige Clinical Research | Franklin | Ohio | 45005 | — |
| Albert J. Weisbrot and Associates | Mason | Ohio | 45040 | — |
| Clinical Research Institute of Southern Oregon, P.C. | Medford | Oregon | 97504 | — |
| Clinical Research Associates of Central PA, LLC | Altoona | Pennsylvania | 16602 | — |
| Heritage Valley Medical Group | Beaver | Pennsylvania | 15009 | — |
| Clinical Research Associates Inc | Nashville | Tennessee | 37203 | — |
| Dallas Diabetes & Endocrine Center at Medical City | Dallas | Texas | 75230 | — |
| Baylor Endocrine Center | Dallas | Texas | 75246 | — |
| Permian Research Foundation | Odessa | Texas | 79761 | — |
| Spectrum Medical, Inc | Danville | Virginia | 24541 | — |
| Dominion Medical Associates, Inc. | Richmond | Virginia | 23219 | — |
| National Clinical Research | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03586830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03586830 live on ClinicalTrials.gov.